Tenon Medical, Inc Files IPO Registration Statement

Tenon Medical, Inc files IPO registration statement.

The company describes itself as: "Tenon Medical, Inc. (“Tenon”), a medical device company formed in 2012, has developed a proprietary, U.S. Food and Drug Administration (“FDA”) cleared surgical implant system, which is designed to optimize sacroiliac joint (“SI-Joint”) fixation / fusion surgery and corresponding outcomes. Tenon is preparing a national launch of this system to address the greatly underserved market opportunity that exists in this space."

The Benchmark Company will serve as sole underwriters.

You May Also Be Interested In

• FDA Committee Recommends To Widen Access To Bpc-157 Peptide
• ReElement Technologies receives $25M from Department of War
• Lyntris files for IPO, plans to list on NYSE under "LYNX"